Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Account Payables (2016 - 2025)

Utah Medical Products has reported Change in Account Payables over the past 16 years, most recently at $142000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $142000.0 for Q4 2025, up 147.02% from a year ago — trailing twelve months through Dec 2025 was $211000.0 (up 389.04% YoY), and the annual figure for FY2025 was $211000.0, up 389.04%.
  • Change in Account Payables for Q4 2025 was $142000.0 at Utah Medical Products, up from $32000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for UTMD hit a ceiling of $695000.0 in Q1 2022 and a floor of -$826000.0 in Q3 2023.
  • Median Change in Account Payables over the past 5 years was $41500.0 (2021), compared with a mean of $6150.0.
  • Biggest five-year swings in Change in Account Payables: plummeted 302.29% in 2021 and later skyrocketed 1262.75% in 2022.
  • Utah Medical Products' Change in Account Payables stood at -$265000.0 in 2021, then soared by 71.32% to -$76000.0 in 2022, then soared by 436.84% to $256000.0 in 2023, then plummeted by 217.97% to -$302000.0 in 2024, then skyrocketed by 147.02% to $142000.0 in 2025.
  • The last three reported values for Change in Account Payables were $142000.0 (Q4 2025), $32000.0 (Q3 2025), and -$180000.0 (Q2 2025) per Business Quant data.